Journey Medical (DERM) Interest & Investment Income (2022 - 2026)
Journey Medical's (DERM) quarterly Interest & Investment Income came in at $157000.0 in Q1 2026, up 5.37% YoY from $149000.0 in Q1 2025, and up 6.08% on a QoQ basis from $148000.0 in Q4 2025.
Journey Medical (DERM) Interest & Investment Income (2022 - 2026) Analysis & Trends
Journey Medical (DERM) has 5 years of Interest & Investment Income data on file, last reported at $157000.0 in Q1 2026.
- Quarterly Interest & Investment Income rose 5.37% year-over-year to $157000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $597000.0 (down 13.35% YoY) and the FY2025 annual result came in at $589000.0, down 22.19% from the prior year.
- Interest & Investment Income grew to $157000.0 in Q1 2026, from $148000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $217000.0 in Q1 2024 to a low of $3000.0 in Q1 2022.
- A 5-year average of $110882.4 and a median of $138000.0 in 2025 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income surged 3966.67% — and 2025, when it tumbled 31.34%.
- Tracing DERM's Interest & Investment Income over 5 years: stood at $50000.0 in 2022, then jumped by 126.0% to $113000.0 in 2023, then soared by 69.03% to $191000.0 in 2024, then decreased by 22.51% to $148000.0 in 2025, then rose by 6.08% to $157000.0 in 2026.
- The last three Interest & Investment Income figures came in at $157000.0 (Q1 2026), $148000.0 (Q4 2025), and $154000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Journey Medical | 205.93 Mn | 180.28 Mn | 12.37 Mn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 154,000.00 |
| Mar 31, 2026 | 157,000.00 |
| Dec 31, 2025 | 148,000.00 |
| Sep 30, 2025 | 154,000.00 |
| Jun 30, 2025 | 138,000.00 |
| Mar 31, 2025 | 149,000.00 |
| Dec 31, 2024 | 191,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 161,000.00 |
| Mar 31, 2024 | 217,000.00 |
| Dec 31, 2023 | 113,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | 79,000.00 |
| Mar 31, 2023 | 122,000.00 |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 3,000.00 |